POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK CYTOGENETICS

Article2019

Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma: Subanalysis of OPTIMISMM

Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Larry D. Anderson, Darrell White, Jesús F. San Miguel, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Eva Casalz, Ruiyun Jiang, Shankar Srinivasan, Tuong Vi Nguyen, Amine Bensmaine, Teresa Peluso, Paul G. Richardson

Article2021

P-224: Pomalidomide, bortezomib, and dexamethasone after 1 prior line of therapy in relapsed or refractory multiple myeloma (RRMM): A safety subanalysis of the phase 3 OPTIMISMM trial

Katja Weisel, Meletios A Dimopoulos, Albert Oriol, Meral Beksaç, Fredrik Dimopoulos, Anna Marina Liberati, Jindriska Lindsay, Darrell White, Jesús F. San Miguel, Philippe Moreau, Larry D. Anderson, Alessandra Lorocca, Pawef Robak, Prisca Vogel, Ruiyun Jiang, Lara Grote, Teresa Peluso, Paul G. Richardson

Article2020

Pomalidomide, bortezomib, and dexamethasone (PVd) in lenalidomide (LEN)-pretreated relapsed refractory multiple myeloma: Subanalysis of patients with renal impairment in OPTIMISMM.

Fredrik Schjesvold, Meletios A Dimopoulos, Meral Beksaç, Albert Oriol, Jindriska Lindsay, Anna Marina Liberati, Mónica Galli, Paweł Robak, Katja Weisel, Alessandra Larocca, Münci Yağcı, Filiz Vural, Larry Anderson, Abraham S. Kanate, Eva Casal Mendez, Ruiyun Jiang, Shankar Srinivasan, Lara Grote, Tsvetan Biyukov, Paul G. Richardson

Article2015

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

Meletios A Dimopoulos, K. Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, L. Garderet, Michèle Cavo, V. L. Ivanova, Adrían Alegre, Joaquín Martínez‐López, Christopher Chen, Andrew Spencer, Stefan Knop, Nizar J. Bahlis, Christoph Renner, Xin Yu, Kevin Hong, Lars Sternås,

Article2014

CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

Meletios A Dimopoulos, Katja Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, Laurent Garderet, Michèle Cavo, Иванова, Adrían Alegre, Joaquín Martínez‐López, C. I Chen, A. Spencer, Stefan Knop, NJ Bahlis, C. Renner, Xiaoyan Yu, Kelvin Hong,

Discussion(0)

Related publications